NCT02835911Active, not recruiting
Clinical Cohort of Lymphoma Patients in Malawi
LCCC 1229: Developing a Prospective Lymphoma Clinical Cohort in Malawi
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
This registry study is intended to establish a large prospective longitudinal clinical cohort of lymphoma patients in Malawi, as such data is currently lacking from sub-Saharan Africa. The investigators will perform core biopsies on at least 800 consecutively enrolled patients with suspected lymphoma for accurate histopathologic characterization. The investigators will systematically collect relevant clinical and laboratory data, and longitudinally follow those with confirmed hematologic malignancies receiving treatment according to local standards of care to assess outcomes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1140 (actual)
- First submitted
- 19 Jan 2016
- Start date
- Apr 2013
- Primary completion date
- Jun 2031
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT02835911
What you commit to
- Study type: Observational
- Participants enrolled: 1140
- From Apr 2013 to the primary completion date, Jun 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- There are no exclusion criteria other than failure to meet inclusion criteria listed above.
Other
- Patients may consent to participation in the study but refuse directed genomic analysis of their lymphoma specimens.
Criteria the registry did not label
- Criteria: Inclusion Criteria:
- Referred to Kamuzu Central Hospital (KCH) with clinically suspected lymphoma based on clinical impression of referring providers Age \>5 years, or ≤5 years only if lymphoma has already been pathologically confirmed.
- No prior or concurrent histologically confirmed cancer diagnosis or receipt of cancer treatment.
- Residence \<200 kilometers from KCH. Able to understand and comply with study procedures for the entire length of the study, with assistance of parent or guardian as applicable.
- Subject (or parent or guardian as applicable) able to understand and provide written consent in English or Chichewa.
- Informed consent reviewed and signed by patient, or for pediatric patients, from parent or guardian.
Age in the registry: 0 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UNC Project Coordinator of this site? Confirm its status | Lilongwe | Malawi | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.